Immunomedics to Present at Cowen and Company 34th Annual Health Care ... NASDAQ We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, ... |
